Caitong International Asset Management Co., LTD Beam Therapeutics Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 4,430 shares of BEAM stock, worth $79,252. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,430Holding current value
$79,252% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
258Shares Held
93.6MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$178 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.87MShares$159 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.48MShares$152 Million1.79% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$137 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$81.2 Million72.77% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.26B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...